Your browser doesn't support javascript.
loading
Budget impact analysis of transurethral water vapor therapy for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in the Spanish national healthcare system.
De la Cuadra-Grande, Alberto; Rioja-Zuazu, Jorge; Domínguez-Esteban, Mario; Torres, Esperanza; Blissett, Rob; Woodward, Emily; Oyagüez, Itziar; Fernández-Arjona, Manuel.
Afiliação
  • De la Cuadra-Grande A; Pharmacoeconomics & Outcomes Research Iberia (PORIB), Madrid, Spain.
  • Rioja-Zuazu J; Urology Department, Clínica Universitaria de Navarra, Navarra, Spain.
  • Domínguez-Esteban M; Urology Department, Hospital Marqués de Valdecilla, Cantabria, Spain.
  • Torres E; Health Economics & Market Access, Boston Scientific Inc, Madrid, Spain.
  • Blissett R; Health Economics & Economic Evaluation, MedTech Economics Ltd, Winchester, UK.
  • Woodward E; Health Economics & Market Access, Boston Scientific AG, Solothurn, Switzerland.
  • Oyagüez I; Pharmacoeconomics & Outcomes Research Iberia (PORIB), Madrid, Spain.
  • Fernández-Arjona M; Urology Department, Hospital Universitario del Henares, Madrid, Spain.
Expert Rev Pharmacoecon Outcomes Res ; 23(5): 499-510, 2023 Jun.
Article em En | MEDLINE | ID: mdl-36897833

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hiperplasia Prostática / Sintomas do Trato Urinário Inferior Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hiperplasia Prostática / Sintomas do Trato Urinário Inferior Idioma: En Ano de publicação: 2023 Tipo de documento: Article